Baricitinib vs Tofacitinib

Baricitinib vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Baricitinib and Tofacitinib.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Tofacitinib — C16H20N6O.

Molecular Weight: Baricitinib — 371.4170 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Baricitinib — Small molecule; Tofacitinib — Small molecule.